| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Shizuru Judith Anne serves as a Director at JSPR. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $381K at current prices.
The biggest single holding is JSPR (~$381K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 41,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 2025 | JSPR Jasper Therapeutics, Inc. | Director | Buy | 41,000 | $2.43 | $99,630.00 | +35.4% | -24.8% | -75.5% |